National guidelines for the best practices in palliative and end-of-life care for lesbian, gay, bisexual, and transgender cancer patients and their families.

Authors

Shail Maingi

Shail Maingi

Montefiore Medical Center, Bronx, NY

Shail Maingi, Sean O'Mahony, Michael G Bare, Liz Margolies, Nfn Scout, Charles Stewart Kamen

Organizations

Montefiore Medical Center, Bronx, NY, Rush University, Chicago, IL, LGBT HealthLink, Fort Lauderdale, FL, The National LGBT Cancer Network, New York, NY, Boston University School of Public Health, Boston, MA, University of Rochester Medical Center, Rochester, NY

Research Funding

No funding sources reported

Background: A growing body of evidence indicates that LGBT communities are disproportionately affected by cancer due to higher rates of traditional risk factors such as tobacco and alcohol, non-inclusion in educational campaigns, and minority stress. Due to the exclusion of sexual orientation and gender identity measures in national oncology databases, there has been difficulty documenting the extent of healthcare disparities that exist for LGBT cancer patients. However, an increasing number of studies describe the experiences of LGBT patients and their families at the end of life. Although societal attitudes and legal protections are shifting, the existing literature clearly indicates that LGBT patients in palliative and end-of-life care settings encounter unique barriers to quality care. For example, LGBT individuals may distrust specific members of palliative care teams, such as a pastor because of past rejections by faith-based communities. Other barriers include high levels of familial rejection, fear of revealing minority status, and a lack of legal protection. Methods: In 2014 and 2015, a CDC-funded multidisciplinary expert panel met to develop the best practices across the cancer care continuum for the LGBT community. The experts drew on available literature and clinical and community experience. They reached a consensus regarding recommendations that were later reviewed using a process that elicited comments from providers, patients, and community and national organizations. Results: Recommendations were made in 7 domains: 1) cancer prevention, 2) cancer screening, 3) diagnosis, 4) treatment, 5) survivorship, 6) palliative and end-of-life care, and 7) public health. Here we report the panel’s recommendations for improving palliative and end-of-life care for LGBT cancer patients. Conclusions: The barriers for LGBT cancer patients to access quality palliative and end-of-life care exist, and the subsequent healthcare disparities are often invisible to healthcare providers. Implementation of these national recommendations will help eliminate the disparities that LGBT patients and their families experience when facing cancer.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2015 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Biologic Basis of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship,Evaluation and Assessment of Patient Symptoms and Quality of Life,Management/Prevention of Symptoms and Treatment Toxicities,Integration and Delivery of Palliative Care in Cancer Care,Psychosocial and Spiritual Care,Communication in Advanced Cancer

Sub Track

Disparities in care

Citation

J Clin Oncol 33, 2015 (suppl 29S; abstr 126)

DOI

10.1200/jco.2015.33.29_suppl.126

Abstract #

126

Poster Bd #

B17

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Description of survivorship recommendations in NCCN guidelines.

First Author: Andrea Anampa-Guzmán

Abstract

2021 ASCO Quality Care Symposium

Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).

First Author: Laura Donovan

Abstract

2020 ASCO Virtual Scientific Program

Primary care provider involvement in thyroid cancer survivorship care.

First Author: Archana Radhakrishnan